Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...

Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...

Researchers have finally seen and measured the tiny alpha-synuclein oligomers that may ignite Parkinson’s disease. With the ...

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...